Revenue

Asia's largest pharma show returns, showcasing China's evolution from the world's factory to a global hub of drug innovation and supply chain strategy.

As Mike Eastwood retires, new CFO Gary Bischoping, a tech and finance veteran, is set to guide the company's ambitious AI transformation and next chapter of growth.

With a strong cash position and promising drug candidate, Apogee Therapeutics is advancing multiple trials to challenge the I&I market with a new therapy.

Riding high on U.S. success, GEEK BAR returns to Europe with a reusable vape, a strategic pivot as the continent wages war on disposable products.

At CONEXPO 2026, Industrial Training International unveils advanced VR training solutions aimed at mitigating risk and rapidly upskilling a new generation of workers.

McFarlane Lake Mining's latest drill results reveal a massive 95.4-meter gold intersection, signaling a major expansion of its Juby gold project.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.

Hain Celestial completes sale of Terra and Garden of Eatin' to pay down debt, betting its future on the high-margin tea, yogurt, and baby food markets.

Drowning in workplace apps? YAROOMS introduces Yarvis, a conversational AI assistant in Teams and email designed to manage your office logistics for you.

At MODEX 2026, KNAPP will unveil its AI-driven 'Brain' and award-winning 3D robots, promising a new era of intelligent, adaptive supply chains.

Private equity giant Warburg Pincus invests up to $1 billion in Global Eggs, fueling a rapid consolidation of the world's protein supply.

Industry legend William Sheriff moves to Verdera Energy, unlocking a major New Mexico uranium portfolio in a strategic spin-out from giant enCore Energy.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

A new DLA contract with REalloys seeks to onshore Samarium and Gadolinium production, vital for defense, using a breakthrough zero-waste technology.

A key clinical milestone for its MS drug azer-cel nets Precision BioSciences $7.5M, extending its financial runway and boosting hope for patients.

The 135-year-old industry pioneer swept the 2026 TRSA awards, showcasing excellence in service, leadership, and sustainability across three continents.

Following strong shareholder support, Azimut Exploration launches a massive drilling campaign targeting deep gold potential and expanding known resources in Quebec.

With a strong cash runway and pivotal trials underway, Sionna Therapeutics aims to revolutionize CF treatment with a novel class of NBD1 stabilizer drugs.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.